Chemotherapy of advanced non-small cell lung cancer in elderly patients

Annals of Oncology

Volumn 17, Issue SUPPL. 2, 2006, Pages

  Rossi, Antonio ^a   Gridelli, C ^a  

^a S G MOSCATI HOSPITAL   (Italy)

Author keywords

Chemotherapy; Elderly patients; Lung cancer; NSCLC

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; ERLOTINIB; GEFITINIB; GEMCITABINE; IMC C 225; NAVELBINE; PACLITAXEL;

ADVANCED CANCER; AGING; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; DRUG CHOICE; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INFUSION; DRUG RESPONSE; DRUG TOLERANCE; ELDERLY CARE; FEASIBILITY STUDY; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; MANDATORY PROGRAM; MONOTHERAPY; NEUTROPENIA; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL TIME; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; HUMANS; LUNG NEOPLASMS; MEDICAL ONCOLOGY; NEOPLASM STAGING; PLATINUM COMPOUNDS; TAXOIDS; VINBLASTINE;

EID: 33645828208     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj925     Document Type: Article

References (17)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156.
2. Silverberg E, Lubera JA. Cancer statistics. CA Cancer J Clin 1988; 38: 5-22.
3. Gridelli C, Perrone F, Monfardini S. Lung cancer in the elderly. Eur J Cancer 1997; 33: 2313-2314.
4. Gridelli C, De Vivo R, Monfardini S. Management of small-cell lung cancer. Crit Rev Oncol Hematol 2002; 41: 79-88.
5. Fentiman IS, Tirelli V, Monfardini S et al. Cancer in the elderly: Why so badly treated? Lancet 1990; 28: 1020-1022.
6. Perrone F, Gallo C, Gridelli C. Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: Implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 2002; 94: 1029-1030.
7. Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999; 91: 66-72.
8. Gridelli C, Shepherd FA. Chemotherapy for elderly patients with non-small cell lung cancer: A review of the evidence. Chest 2005; 128: 947-957.
9. Takeda K, Kudoh S, Nakagawa K et al. Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904). J Clin Oncol 2005; 23 (16S): 623s (Abstr 7009).
10. Frasci G, Lorusso V, Panza N et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small cell lung cancer. J Clin Oncol 2000; 18: 2529-2536.
11. Gridelli C, Perrone F, Gallo C et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III randomized trial. J Natl Cancer Inst 2003; 95: 362-372.
12. Rossi A, Maione P, Gridelli C. Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients. Expert Opin Drug Saf 2005; 4: 1051-1067.
13. Gridelli C, Rossi A, Galetta D et al. Italian clinical research in non-small-cell lung cancer. Ann Oncol 2005; 16 (Suppl. 4): 110-115.
14. Scagliotti G, Rossi A, Novello S et al. Gefitinib (ZD1839) combined with gemcitabine or vinorelbine as single-agent in elderly patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2004; 23: 633 (Abstr. 7081).
15. Jackman D, Lucca J, Fidias P et al. Phase II study of the EGFR tyrosine kinase erlotinib in patients ≥ 70 years of age with previously untreated advanced non-small cell lung cancer. J Clin Oncol 2005; 23 (16S): 657s (Abstr. 7148).
16. Pfister DG, Johnson DH, Azzoli CG et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22: 330-353.
17. Gridelli C, Aapro M, Ardizzoni A et al. Treatment of advanced non-small-cell lung cancer in the elderly: Results of an international export panel. J Clin Oncol 2005; 23: 3125-3137.